These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 6147816)
1. Acute stimulation of ganglionic tyrosine hydroxylase activity by secretin, VIP and PHI. Ip NY; Baldwin C; Zigmond RE Peptides; 1984; 5(2):309-12. PubMed ID: 6147816 [TBL] [Abstract][Full Text] [Related]
2. Secretin and vasoactive intestinal peptide acutely increase tyrosine 3-monooxygenase in the rat superior cervical ganglion. Ip NY; Ho CK; Zigmond RE Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7566-9. PubMed ID: 6130526 [TBL] [Abstract][Full Text] [Related]
3. Regulation of the concentration of adenosine 3',5'-cyclic monophosphate and the activity of tyrosine hydroxylase in the rat superior cervical ganglion by three neuropeptides of the secretin family. Ip NY; Baldwin C; Zigmond RE J Neurosci; 1985 Jul; 5(7):1947-54. PubMed ID: 2862228 [TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal peptide and secretin produce long-term increases in tyrosine hydroxylase activity in the rat superior cervical ganglion. McKeon TW; Zigmond RE Brain Res; 1993 Apr; 607(1-2):345-8. PubMed ID: 8097667 [TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal polypeptide-related peptides modulate tyrosine hydroxylase gene expression in PC12 cells through multiple adenylate cyclase-coupled receptors. Wessels-Reiker M; Basiboina R; Howlett AC; Strong R J Neurochem; 1993 Mar; 60(3):1018-29. PubMed ID: 8094740 [TBL] [Abstract][Full Text] [Related]
6. Activation of ganglionic tyrosine hydroxylase by peptides of the secretin-glucagon family: structure-function studies. Schwarzschild MA; Vale W; Corigliano-Murphy AC; Pisano JJ; Ip NY; Zigmond RE Neuroscience; 1989; 31(1):159-67. PubMed ID: 2570376 [TBL] [Abstract][Full Text] [Related]
7. Secretin and vasoactive intestinal peptide activate tyrosine hydroxylase in sympathetic nerve endings. Schwarzschild MA; Zigmond RE J Neurosci; 1989 Jan; 9(1):160-6. PubMed ID: 2563276 [TBL] [Abstract][Full Text] [Related]
8. Regulation of tyrosine hydroxylase activity in rat PC12 cells by neuropeptides of the secretin family. Roskoski R; White L; Knowlton R; Roskoski LM Mol Pharmacol; 1989 Dec; 36(6):925-31. PubMed ID: 2574821 [TBL] [Abstract][Full Text] [Related]
9. Secretin, VIP, and PHI stimulate rat proximal duodenal surface epithelial bicarbonate secretion in vivo. Isenberg JI; Wallin B; Johansson C; Smedfors B; Mutt V; Tatemoto K; Emas S Regul Pept; 1984 Jul; 8(4):315-20. PubMed ID: 6548570 [TBL] [Abstract][Full Text] [Related]
10. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini. Zhou ZC; Gardner JD; Jensen RT Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694 [TBL] [Abstract][Full Text] [Related]
11. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology. Christophe J; Waelbroeck M; Chatelain P; Robberecht P Peptides; 1984; 5(2):341-53. PubMed ID: 6089134 [TBL] [Abstract][Full Text] [Related]
12. Porcine peptide having N-terminal histidine and C-terminal isoleucine amide (PHI): vasoactive intestinal peptide (VIP) and secretin-like effects in different tissues from the rat. Bataille D; Gespach C; Laburthe M; Amiranoff B; Tatemoto K; Vauclin N; Mutt V; Rosselin G FEBS Lett; 1980 Jun; 114(2):240-2. PubMed ID: 6248367 [No Abstract] [Full Text] [Related]
14. Postreceptor modulation of action of VIP and secretin on pancreatic enzyme secretion by secretagogues that mobilize cellular calcium. Collen MJ; Sutliff VE; Pan GZ; Gardner JD Am J Physiol; 1982 Apr; 242(4):G423-8. PubMed ID: 6175231 [TBL] [Abstract][Full Text] [Related]
15. Effects of peptides of the secretin-glucagon family and cyclic nucleotides on tyrosine hydroxylase activity in sympathetic nerve endings. Schwarzschild MA; Zigmond RE J Neurochem; 1991 Feb; 56(2):400-6. PubMed ID: 1703218 [TBL] [Abstract][Full Text] [Related]
16. Effect of vasoactive intestinal peptide, somatostatin, neurotensin, cholecystokinin octapeptide, and secretin on intestinal absorption of amino acid in rat. Chen YF; Feng ZT; Wen SH; Lu GJ Dig Dis Sci; 1987 Oct; 32(10):1125-9. PubMed ID: 2888609 [TBL] [Abstract][Full Text] [Related]
17. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes. Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504 [TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of muscarinic agonists and secretin or vasoactive intestinal peptide on the regulation of tyrosine hydroxylase activity in sympathetic neurons. Ip NY; Zigmond RE J Neurobiol; 2000 Jan; 42(1):14-21. PubMed ID: 10623897 [TBL] [Abstract][Full Text] [Related]
19. Actions of a newly isolated intestinal peptide PHI on pancreatic acini. Jensen RT; Tatemoto K; Mutt V; Lemp GF; Gardner JD Am J Physiol; 1981 Dec; 241(6):G498-502. PubMed ID: 6172986 [TBL] [Abstract][Full Text] [Related]